South Korean medical imaging AI company Neurophet has received second clearance for its brain image analysis software in the United States.
It obtained another 510(k) from the US Food and Drug Administration for the latest functionality on Neurophet Aqua that analyses multiple sclerosis and white matter hyperintensities using T2-FLAIR images.
The brain MRI scan-based analysis software, which...
Safety-focused large language model company Hippocratic AI has been issued its first patent by the U.S. Patent Office, which includes the company's LLM innovations incorporated into its safety-focused LLM built with a constellation architecture dubbed Polaris.
Hippocratic AI's generative AI solution focuses on nondiagnostic healthcare tasks such as medication onboarding and monthly reconciliation...
Vuno receives second 510(k)
South Korean medical AI company Vuno has obtained a 510(k) clearance from the United States Food and Drug Administration for its chest X-ray analysis AI software.
The VunoMed Chest X-ray Triage quickly screens for pneumothorax and pleural effusion in chest X-ray images.
This FDA win is a second for Vuno, who first received a 510(k) for its brain image analysis AI in...
A new company under financial investment firm SOL Partnership has launched what could be the first at-home gut health test service powered by AI in Malaysia.
SpaceGut offers an at-home gut microbiome kit and a laboratory service that provides personalised recommendations for an individual's gut health. Leveraging a proprietary AI, its laboratory evaluates samples compared against a database of...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
The Society of General Internal Medicine released a position statement on generative AI use in healthcare, highlighting the need for clinicians and technologists to partner to enhance genAI decision-making and for healthcare organizations to use the technology but, avoid "the urge to rapidly displace the human clinical workforce with generative AI."
The Society says clinicians must remain...
Founder and former CEO of the London-based multinational digital health giant Babylon, Ali Parsa, announced the launch of his new company, Quadrivia AI, which will offer clinicians an AI assistant to help with administrative and clinical tasks.
Quadrivia's offering, Qu, is an AI-enabled personal clinical assistant available in multiple languages designed to support clinicians with various tasks...
Neurophet sets up China JV
Medical imaging AI company Neurophet from South Korea has established a joint venture in China.
It recently signed an exclusive deal with LADO, one of the leading medical software providers in China, to market its AI-based software for quantifying levels of Alzheimer's disease biomarkers in PET images.
The deal, which also establishes a joint venture with LADO, aims...
AI startup Research Grid, which helps medical research institutions automate administrative tasks for clinical trials, announced it raised $6.5 million in seed funding.
Fuel Ventures led the round with participation from Ada Ventures, Arve Capital, Arāya Ventures, Morgan Stanley Inclusive Ventures Lab, Plug and Play Ventures, Atomico Angels and Ascension Ventures.
WHAT IT DOES
Research Grid is...
